Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
12:30pm, Monday, 13'th Jul 2020
FLORHAM PARK, N.J., July 13, 2020 -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing.
Lannett to cut jobs following FDA approval of competing generic drug
11:34am, Monday, 13'th Jul 2020
Shares of Lannett Company Inc. undefined gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that...
Lannett to cut jobs following FDA approval of competing generic drug
11:34am, Monday, 13'th Jul 2020
Shares of Lannett Company Inc. gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that its generic fluphenazine product will face competitio
Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA
12:00pm, Friday, 10'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (
Amneal Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
11:18am, Thursday, 09'th Jul 2020
Amneal Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.
Amneal Pharmaceuticals (AMRX) Stock Sinks As Market Gains: What You Should Know
09:50pm, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.51, moving -0.66% from the previous trading session.
Amneal to Report Second Quarter 2020 Results on August 6, 2020
12:00pm, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to market open. The Company will ho
Amneal to Report Second Quarter 2020 Results on August 6, 2020
12:00am, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August
AMRX vs. COLL: Which Stock Should Value Investors Buy Now?
03:40pm, Tuesday, 07'th Jul 2020
AMRX vs. COLL: Which Stock Is the Better Value Option?
Parametric Portfolio Associates LLC Grows Stock Position in Amneal Pharmaceuticals Inc (NYSE:AMRX)
04:28am, Sunday, 05'th Jul 2020
Parametric Portfolio Associates LLC grew its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 17.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 236,760 shares of the compa
51,034 Shares in Amneal Pharmaceuticals Inc (NYSE:AMRX) Acquired by Voloridge Investment Management LLC
07:28am, Saturday, 04'th Jul 2020
Voloridge Investment Management LLC bought a new position in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) during the first quarter, according to its most recent Form 13F filing with the SEC. The f
Alliancebernstein L.P. Sells 19,700 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
06:44am, Saturday, 04'th Jul 2020
Alliancebernstein L.P. reduced its stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 8.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Co
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Pfizer (NYSE: PFE) - Markets
03:52pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX
How R&D Expenses Can Help You Pick Outperforming Stocks
12:13pm, Thursday, 02'nd Jul 2020
A simple two-rule screen can help you pick R&D-intensive stocks primed to outperform. The differences between R&D expenditures and capital expenditures vary bet
CytoDyn Signs MOU With NIH of Mexico for Coronavirus Study
02:21pm, Tuesday, 30'th Jun 2020
CytoDyn's (CYDY) shares rise more than 20% as it inks an MOU with NIH of Mexico to conduct a COVID-19 study on leronlimab.
